Professor Guymer is Australia’s only academic ophthalmologist to focus exclusively on age-related macular degeneration (AMD), the most common cause of poor vision in our society. She established new AMD treatment clinics at the Royal Victorian Eye and Ear Hospital (the first Australian public hospital to do so); delivered state-of-the-art imaging and functional techniques; and contributed to a commercial genetic test to assess a person’s risk of AMD. Prof Guymer leads the world’s-first nanosecond laser intervention trial, which will revolutionise prophylactic treatment for AMD if successful. She has achieved distinction, frequently providing expert opinion to government, media and support groups.
Menu